U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07209176) titled 'Physician- and Patient-based Barriers to NGS Testing' on Sept. 30.
Brief Summary: The goal of this study is to improve next-generation sequencing (NGS) testing rates at Johns Hopkins in patients with metastatic prostate cancer. Investigators believe by targeting two barriers, provider-level and patient-level, will improve the testing rate of NGS at Johns Hopkins.
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
Metastatic Prostate Cancer
Intervention:
OTHER: Provider-level
The provider level component will involve an email to each of the genitourinary medical oncologists at Johns Hopkins with their NGS testing r...